GHSI has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
GHSI has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Guardion Health Sciences's accounts receivables for the quarter that ended in Mar. 2024 was $2.10 Mil.
Accounts receivable can be measured by Days Sales Outstanding. Guardion Health Sciences's Days Sales Outstanding for the quarter that ended in Mar. 2024 was 63.97.
In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Guardion Health Sciences's Net-Net Working Capital per share for the quarter that ended in Mar. 2024 was $0.98.
The historical data trend for Guardion Health Sciences's Accounts Receivable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guardion Health Sciences Annual Data | |||||||||||||||||||
Trend | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | ||||||||||
Accounts Receivable | Get a 7-Day Free Trial | 0.08 | 0.01 | 1.41 | 1.92 | 2.27 |
Guardion Health Sciences Quarterly Data | ||||||||||||||||||||
Jun19 | Sep19 | Dec19 | Mar20 | Jun20 | Sep20 | Dec20 | Mar21 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | Dec23 | Mar24 | |
Accounts Receivable | Get a 7-Day Free Trial | 1.95 | 1.56 | 1.77 | 2.27 | 2.10 |
Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
Guardion Health Sciences's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:
Days Sales Outstanding | |||||
= | Accounts Receivable | / | Revenue | * | Days in Period |
= | 2.103 | / | 3 | * | 91 |
= | 63.97 |
2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Guardion Health Sciences's accounts receivable are only considered to be worth 75% of book value:
Guardion Health Sciences's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2024 is calculated as:
Net-Net Working Capital Per Share | |||||||
= | (Cash And Cash Equivalents | + | 0.75 * Accounts Receivable | + | 0.5 * Total Inventories | - | Total Liabilities |
- | Preferred Stock | - | Minority Interest) | / | Shares Outstanding (EOP) | ||
= | (5.605 | + | 0.75 * 2.103 | + | 0.5 * 2.134 | - | 6.993 |
- | 0 | - | 0) | / | 1.28416 | ||
= | 0.98 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.
If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.
Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.
Thank you for viewing the detailed overview of Guardion Health Sciences's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.
Katharine Joan Cox | officer: Chief Accounting Officer | 2925 RICHMOND AVENUE, SUITE 1200, HOUSTON TX 77098 |
Janet Hall | officer: CEO & President | 2925 RICHMOND AVENUE, SUITE 1200, HOUSTON TX 77098 |
Bradley Louis Radoff | 10 percent owner | 2727 KIRBY DRIVE, UNIT 29L, HOUSTON TX 77098 |
Family Foundation Radoff | other: See Footnote 1 | 2727 KIRBY DRIVE, UNIT 29L, HOUSTON TX 77098 |
Michaela Griggs | director | 2925 RICHMOND AVENUE, SUITE 1200, HOUSTON TX 77098 |
Bret Scholtes | director, officer: Chief Executive Officer | 2105 CITY WEST BLVD., SUITE 500, HOUSTON TX 77042 |
Donald A Gagliano | director | 131 CARDINAL AVE, SAN ANTONIO TX 78209 |
Jeffrey S Benjamin | officer: Chief Accounting Officer | 3885 CRESTWOOD PARKWAY, SUITE 550, DULUTH GA 30096 |
Craig Sheehan | officer: Chief Commercial Officer | 15150 AVENUE OF SCIENCE, SUITE 200, SAN DIEGO CA 92128 |
Andrew C Schmidt | officer: Chief Financial Officer | 1700 CARNEGIE AVE, SUITE 100, SANTA ANA CA 92705 |
Kelly Anderson | director | C/O TOMI ENVIRONMENTAL SOLUTIONS, INC., 9454 WILSHIRE BLVD., R-1, BEVERLY HILLS CA 90212 |
David W Evans | director, officer: Chief Scientific Officer | 4141 JUTLAND DRIVE, SUITE 215, SAN DIEGO CA 92117 |
Tamara A Evans | 10 percent owner | 4141 JUTLAND DRIVE, SUITE 215, SAN DIEGO CA 92117 |
Vincent J Roth | officer: General Counsel and Secretary | 15150 AVENUE OF SCIENCE, SUITE 200, SAN DIEGO CA 92128 |
Robert N Weingarten | director | 5439 LOCKHURST DRIVE, WOODLAND HILLS CA 91367 |
From GuruFocus
By GlobeNewswire GlobeNewswire • 01-06-2023
By sperokesalga sperokesalga • 05-15-2023
By GuruFocusNews GuruFocusNews • 07-01-2022
By GuruFocusNews GuruFocusNews • 06-05-2022
By GuruFocusNews GuruFocusNews • 06-11-2022
By GuruFocusNews GuruFocusNews • 06-09-2022
By GuruFocusNews GuruFocusNews • 06-11-2022
By Value_Insider Value_Insider • 11-29-2022
By sperokesalga sperokesalga • 04-17-2023
By GuruFocusNews GuruFocusNews • 06-21-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.